Piperonyl Butoxide
CAS 51-03-6
Piperonyl Butoxide (CAS 51-03-6) is a Phase 4 pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 28163.72857142857 nM | 13 | - |
| - | IC50 | 5200 nM | 6 | - |
| - | AC50 | 12854.733333333332 nM | 3 | - |
| Cytochrome P450 3A4 Enzyme |
IC50 | 5.52 | - | Homo sapiens |
| Cytochrome P450 Enzyme |
INHIBITOR | - | - | Pediculus humanus subsp. corporis |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| PIPERONYL BUTOXIDE | 8345 | SU | MTHSPL |
| piperonyl butoxide | 8345 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Piperonyl Butoxide used for in pharmaceutical contexts?
Piperonyl Butoxide (CAS 51-03-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Piperonyl Butoxide?
No adverse-event association or SIDER side-effect rows are rendered for Piperonyl Butoxide in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Piperonyl Butoxide also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Piperonyl Butoxide with EU status "prohibited".
What clinical phase is Piperonyl Butoxide in?
Piperonyl Butoxide is rendered with ChEMBL max phase 4 (approved).
What bioactivity targets are documented for Piperonyl Butoxide?
Piperonyl Butoxide has 5 bioactivity rows in this page query. Rendered target entries include Cytochrome P450 3A4, Cytochrome P450.